139 related articles for article (PubMed ID: 725323)
1. Enhancement of melphalan therapy with glutaminase:asparaginase.
Vistica DT; Rabon A; Rabinovitz M
Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
[TBL] [Abstract][Full Text] [Related]
2. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
Holcenberg JS
Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
[TBL] [Abstract][Full Text] [Related]
4. Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults.
Warrell RP; Chou TC; Gordon C; Tan C; Roberts J; Sternberg SS; Philips FS; Young CW
Cancer Res; 1980 Dec; 40(12):4546-51. PubMed ID: 7438089
[TBL] [Abstract][Full Text] [Related]
5. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
Vistica DT; Toal JN; Rabinovitz M
Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
[No Abstract] [Full Text] [Related]
7. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase.
Rosenfeld H; Roberts J
Cancer Res; 1981 Apr; 41(4):1324-8. PubMed ID: 7214322
[TBL] [Abstract][Full Text] [Related]
8. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
Vistica DT; Toal JN; Rabinovitz M
Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
[No Abstract] [Full Text] [Related]
9. Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase-asparaginases.
Schmid FA; Roberts J
Cancer Chemother Rep; 1974; 58(6):829-40. PubMed ID: 4447925
[No Abstract] [Full Text] [Related]
10. Effect of Acinetobacter glutaminase-asparaginase treatment on free amino acids in mouse tissues.
Holcenberg JS; Tang E; Dolowy WC
Cancer Res; 1975 May; 35(5):1320-5. PubMed ID: 1091350
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen utilization in mice bearing Ehrlich ascites tumor treated with Acinetobacter glutaminase-asparaginase.
Kien CL; Holcenberg JS
Cancer Res; 1981 Jun; 41(6):2051-5. PubMed ID: 7237413
[TBL] [Abstract][Full Text] [Related]
12. Enzyme therapy of cancer, future studies.
Holcenberg JS
Cancer Treat Rep; 1981; 65 Suppl 4():61-5. PubMed ID: 7346158
[TBL] [Abstract][Full Text] [Related]
13. Thiamine protection of murine L1210 leukemia cells against mechlorethamine cytotoxicity and its relation to the choline uptake system.
Naujokaitis SA
Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):317-27. PubMed ID: 7244366
[TBL] [Abstract][Full Text] [Related]
14. Effect of succinylated Acinetobacter glutaminase-asparaginase treatment on an acute myeloid leukemia in the rat (BNML).
Sonneveld P; Holcenberg JS; van Bekkum DW
Eur J Cancer (1965); 1979 Aug; 15(8):1061-3. PubMed ID: 292598
[No Abstract] [Full Text] [Related]
15. Amino acid utilization and urine protein excretion in children treated with succinylated Acinetobacter glutaminase-asparaginase.
Kien CL; Holcenberg JS
Cancer Res; 1981 Jun; 41(6):2056-62. PubMed ID: 7016307
[TBL] [Abstract][Full Text] [Related]
16. [Induced synthesis of asparaginase and glutaminase by Pseudomonas sp].
Evseev LP; Nikolaev AIa; Eremenko VV; Mardashev SR
Biokhimiia; 1967; 32(4):873-5. PubMed ID: 5592304
[No Abstract] [Full Text] [Related]
17. Sensitivity of cultured pancreatic carcinoma cells to Acinetobacter glutaminase-asparaginase.
Wu MC; Arimura GK; Holcenberg JS; Yunis AA
In Vitro; 1982 Sep; 18(9):750-4. PubMed ID: 7173949
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
Avery TL; Roberts D
Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
[No Abstract] [Full Text] [Related]
19. Tissue nitrogen-sparing effect of high protein diet in mice with or without ascites tumor treated with Acinetobacter glutaminase-asparaginase.
Kien CL; Anderson AJ; Holcenberg JS
Cancer Res; 1985 Oct; 45(10):4876-82. PubMed ID: 4027974
[TBL] [Abstract][Full Text] [Related]
20. Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.
Abuchowski A; van Es T; Palczuk NC; McCoy JR; Davis FF
Cancer Treat Rep; 1979 Jun; 63(6):1127-32. PubMed ID: 466651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
